Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Juul Halts Sale of Fruit, Dessert Flavors of E-CigarettesShrinking Youth Group Aids Global Decline in HomicidesWhen Meds Are Free, Patients Take Them More OftenSpurred by Mass Shootings, More Americans View Mentally Ill as ViolentPacemakers, Insulin Pumps Could Be Hacking Targets: FDAAHA News: Make Neighborhoods Green for Heart Health? The Idea Is Taking RootPoll Finds Many Young Americans Think Vaping is SafeWhat Do Hospital Cyber Attackers Want to Know About You?U.S. Minorities' Recent Health Gains May Be SlowingPaid Family Leave Helps Keep Babies' Vaccines on Track: StudyDon't Let Fear of Cancer Keep You From Doctor VisitsMaker Halts Distribution of Generic Zantac Due to Possible CarcinogenCould Profit Be a Factor in Kidney Transplant Decisions?Get Up-to-the-Minute Safety Alerts Sent Straight to Your InboxPurdue Pharma to Settle Opioid Crisis Lawsuits, May Pay Up to $12 BillionWould a Health Warning on Every Cigarette Help Smokers Quit?Docs Prescribe More Opioids at Certain Time of DayFDA Warns Juul About Illegal Marketing Claims and Pitch to YouthComing Soon: A 'Pot Breathalyzer'?More CT, MRI Scans Being Used, Despite Calls to Cut BackCancer Overtakes Heart Disease as #1 Killer of Middle-Aged in Wealthy NationsOxyContin Maker Purdue Offering Up to $12 Billion to Settle Opioid ClaimsThousands of Kidneys Thrown Away by U.S. Transplant CentersJudge Orders Johnson & Johnson to Pay $572 Million Over Opioid Drug CrisisEvery Sudden Infant Death Deserves a Closer Look: ReportYour Chocolate Pot 'Edible' Could Hold a Hidden DangerCBD Is the Rage, But More Science Needed on Safety, EffectivenessMany Parents Would Switch Doctors Over Vaccination Policy, Poll FindsPot Poisonings Among Kids, Teens Double After Medical Marijuana Law PassedNearly Half of U.S. Patients Keep Vital Secrets From Their DoctorsFDA Proposes Graphic Warning Labels on CigarettesMany Doctors Refusing Care of People Prescribed OpioidsAll U.S. Adults Should Be Screened for Illicit Drug Use, National Panel UrgesAmericans' Trust in Scientists Follows a Sharp Political DivideRaising Legal Smoking Age to 21 WorksPure CBD Won't Make You Fail a Drug Test, But…Health Tip: Donate Blood SafelyRoutine Screening for Pancreatic Cancer Not Warranted, Expert Panel SaysResearchers 'Spin' Clinical Trial Findings in Top Psych Journals: StudyMore 'Buyer Beware' Warnings for Unregulated Stem Cell ClinicsSome of Most Common, Deadly Cancers Get the Least Research MoneyTraveling Abroad? Make Sure Your Measles Shot Is Up to DateHey! That's the Wrong Knee, DoctorBlood Donations Needed: Red CrossKeep Unused Meds Out of the Hands of AddictsFew U.S. Universities Are Smoke-FreeNeed Emergency Air Lift to Hospital? It Could Cost You $40,000California Took on Anti-Vaxxers, and WonAnti-Vaccine Movement a 'Man-Made' Health Crisis, Scientists WarnAHA News: Even the Threat of Homelessness May Bring Higher Stroke Risk
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

FDA Halts All Sales of Pelvic Mesh Products Tied to Injuries in Women

HealthDay News
by -- Robert Preidt
Updated: Apr 16th 2019

new article illustration

TUESDAY, April 16, 2019 (HealthDay News) -- The U.S. Food and Drug Administration on Tuesday announced a ban on the sale of all pelvic mesh products.

The surgical mesh is typically used to repair pelvic organ prolapse (POP) and incontinence, but reported side effects have included permanent incontinence, severe discomfort and an inability to have sex.

"In order for these mesh devices to stay on the market, we determined that we needed evidence that they worked better than surgery without the use of mesh to repair POP," said Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health. "That evidence was lacking in these premarket applications, and we couldn't assure women that these devices were safe and effective long term."

Simply put, the remaining makers of the mesh devices -- Boston Scientific and Coloplast -- failed to prove the long-term safety or benefit of their devices, the FDA said in a news release.

The companies will have 10 days to submit plans to withdraw these products from the market, the FDA said. Most pelvic mesh products have already been taken off the market, according to the Associated Press.

The products are the subjects of lawsuits by the states of Washington, California, Kentucky and Mississippi. Those states claim that pelvic mesh maker Johnson & Johnson did not fully disclose safety risks, the AP has reported.

But some doctors who specialize in female pelvic medicine oppose the lawsuits, saying the procedure can work for some women.

Dr. Elizabeth Kavaler is a New York City urologist. She called the agency's move "draconian."

"I have performed over 4,000 vaginal mesh repairs for women with incontinence and pelvic organ prolapse in New York City, with minimal complications and no mortality," Kavaler said. "Speaking as a woman, surgeon, scientist and healer, I know the decision by the FDA to pull vaginal mesh is a disservice to women."

"Robust scientific data, with randomized controlled studies, is available to support the safety and efficacy of vaginal mesh in the right hands," she added. "This decision now forces women, who need surgery, to undergo hysterectomies, removal of healthy organs (ovaries), and necessitates risky, painful, expensive and unnecessary abdominal operations."

Surgical mesh has been used since the 1950s to repair abdominal hernias. Implanting surgical mesh for abdominal repair of POP began in the 1970s. In 2002, the first mesh device for transvaginal repair of POP was approved by the FDA as a moderate-risk device.

About one in eight women will need surgery to repair POP, and a portion of such surgeries have been done transvaginally with the use of surgical mesh.

However, the FDA has issued repeated warnings about the risks associated with using transvaginal mesh for POP repair.

Women who've had the procedure should continue with routine check-ups. No additional measures are needed if they are satisfied with their surgery and don't have complications or symptoms, the FDA said Tuesday.

Those who do have complications or symptoms -- such as persistent vaginal bleeding or discharge, pelvic or groin pain or pain with sex -- should see their health care provider, the agency added.

They should also inform their health care provider if they have surgical mesh, especially if they're scheduled for another surgery or medical procedure.

Women who were planning to have transvaginal mesh repair of POP should discuss other treatment options with their doctors, the FDA advised.

More information

The National Association for Continence has more on pelvic organ prolapse.




Facebook

Amazon Smile

To quit smoking, call Connecticut QuitLine at 1-800-QUIT-NOW.

Children and Adult services are available now with no wait time.  Please contact HBH Intake Department at 860-548-0101, option 2.

 


powered by centersite dot net